Last reviewed · How we verify
NCT05358769
A Study of Incoxil Food Supplement in Female Patients With Stress Dominant Urinary Incontinence.
NA trial testing Incoxil food supplement and pelvic floor muscle exercise in Urinary Incontinence in 36 participants. Completed in 9 September 2022.
9 September 2022
Quick facts
| Lead sponsor | FEMPHARMA Kft. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 27 April 2022 |
| Primary completion | 9 September 2022 |
| Estimated completion | 9 September 2022 |
| Sites | 1 location across Hungary |
Drugs / interventions tested
- Incoxil food supplement and pelvic floor muscle exercise
- Pelvic floor muscle exercise
Conditions studied
- Urinary Incontinence — all drugs for Urinary Incontinence →
Sponsor
FEMPHARMA Kft. — full company profile →
Who can join
18 and older, female only, with Urinary Incontinence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is compare the effectiveness of Incoxil food supplement and pelvic floor muscle training with pelvic floor muscle training alone in the treatment of women with stress dominant urinary incontinence.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle training in women with stress-predominant urinary incontinence.
Takacs P, Pákozdy K, Koroknai E, Erdődi B, et al · · 2023 · cited 3× · PMID 37340306 · DOI 10.1186/s12905-023-02476-z
Verify or expand the search:
- PubMed search for NCT05358769
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urinary Incontinence
Currently open trials in the same condition.
- NCT07430865 — The RECOVER Study - Postpartum Recovery of Pelvic Floor Structures and the Impact of Early Rehabilitation · NA · recruiting
- NCT07105150 — Efficacy of a Video-Based Educational Program on Female Urinary Incontinence · NA · recruiting
- NCT07426861 — Pre-Operative Nurse-Led Education With Direct Physiotherapy Referral to Reduce Post-Prostatectomy Incontinence · NA · recruiting
- NCT07413692 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and E · NA · recruiting
- NCT07413705 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and · NA · recruiting
Other FEMPHARMA Kft. trials
Trials by the same sponsor.
- NCT06748989 — Cognitive Effects of a Dietary Supplement With PQQ, GABA, Caffeine, and B-Vitamins in Healthy Postmenopausal Women: A Ra · NA · recruiting
- NCT05895162 — Zinc-containing Vaginal Gel and Oral Fluconazole for Vulvovaginal Candidiasis. · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05358769 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by FEMPHARMA Kft.
- Last refreshed: 15 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05358769.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing